FDA — authorised 5 July 2013
- Application: NDA205764
- Marketing authorisation holder: LINDE NORTH AMERICA INC
- Status: approved
FDA authorised Air on 5 July 2013 · 922 US adverse-event reports
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Yes. FDA authorised it on 5 July 2013; FDA authorised it on 5 July 2013; FDA authorised it on 5 July 2013.
LINDE NORTH AMERICA INC holds the US marketing authorisation.